āļ„āļđāđˆāļĄāļ·āļ­āļ­āļļāļ•āļŠāļēāļŦāļāļĢāļĢāļĄ

AI in Kidney Disease and Nephrology

AI kidney models use electronic records and laboratory trends to estimate risk of acute kidney injury or chronic kidney disease progression.

āļŸāļąāļ‡āļ„āļģāđāļ™āļ°āļ™āļģāļ™āļĩāđ‰āļšāļĢāļĢāļĒāļēāļĒāđ‚āļ”āļĒ AI · ~3 min

āļšāļ™āļŦāļ™āđ‰āļēāļ™āļĩāđ‰āļ­āđˆāļēāļ™ 3 āļ™āļēāļ—āļĩ
  1. āļ āļēāļžāļĢāļ§āļĄ
  2. āđ€āļˆāļēāļ°āļĨāļķāļ
  3. āļāļēāļĢāđƒāļŠāđ‰āļ‡āļēāļ™āļˆāļĢāļīāļ‡āđƒāļ™āđ‚āļĨāļāđāļŦāđˆāļ‡āļ„āļ§āļēāļĄāđ€āļ›āđ‡āļ™āļˆāļĢāļīāļ‡
  4. The Future of AI in Kidney Disease and Nephrology
  5. āļāļēāļĢāļ™āļģāđ„āļ›āļ›āļāļīāļšāļąāļ•āļī
  6. āļŠāļģāļĢāļ§āļˆāļ•āđˆāļ­āđ„āļ›
  7. āļ„āļģāļ–āļēāļĄāļ—āļĩāđˆāļžāļšāļšāđˆāļ­āļĒ

āļ āļēāļžāļĢāļ§āļĄ

They matter because earlier risk signals may help a care team focus review, but a prediction is not a diagnosis and does not replace clinician judgment or guideline-based monitoring.

āđ€āļˆāļēāļ°āļĨāļķāļ

Kidney care uses repeated measurements and clinical context. Acute kidney injury can develop during hospitalization, while chronic kidney disease progression is assessed over time using measures such as estimated glomerular filtration rate (eGFR) and urine albumin. AI models may analyze laboratory trends, vital signs, medications and diagnoses in electronic records to estimate a future risk or identify a change that merits closer review. They are intended to support attention and planning, not to diagnose kidney disease from a score alone. One multicenter validation study of a machine-learning AKI risk model included nearly 496,000 hospital admissions across six hospitals in three health systems. It tested the model internally and at other sites; alert thresholds preceded the recorded event by nearly a day and a half. This was a retrospective study with defined inclusion and exclusion criteria, not proof that deploying the alert prevents injury or improves outcomes. Some models have limited evidence for patients with advanced kidney disease, incomplete lab histories or care outside the hospitals where they were developed. For CKD, KDIGO’s 2024 guideline emphasizes assessment of GFR and albuminuria to monitor progression and individualize the frequency of testing. A model may help organize trends or estimate risk, but it should be checked against reliable measurements and the patient’s history. A clinician should consider data gaps, changing conditions and whether an alert is calibrated for the local population. Overreacting to normal variation can trigger unnecessary testing, while a missed alert can create false reassurance. AI can make records easier to scan; the care team determines whether a result warrants action.

āļāļēāļĢāđƒāļŠāđ‰āļ‡āļēāļ™āļˆāļĢāļīāļ‡āđƒāļ™āđ‚āļĨāļāđāļŦāđˆāļ‡āļ„āļ§āļēāļĄāđ€āļ›āđ‡āļ™āļˆāļĢāļīāļ‡

A hospital model flags a rising acute-kidney-injury risk, prompting a clinician to review recent labs, fluid status and medications.

A CKD clinic compares a progression-risk estimate with serial eGFR and urine albumin-to-creatinine results.

A data team tests a risk model at hospitals not used for training before considering clinical workflow integration.

A clinician explains that an alert shows elevated risk over a defined period, not certainty that kidney injury will occur.

The Future of AI in Kidney Disease and Nephrology

Future kidney tools may connect risk estimates with lab timelines and medication review inside electronic records. Such integration could make trends easier to notice, but it could also add alerts or amplify biased records. Prospective studies should test whether clinician response to predictions improves care, rather than only measuring model accuracy. Systems should show the time horizon and evidence behind a flag, support correction of missing inputs and avoid implying certainty. Nephrology teams will continue to interpret results in light of each patient’s history.

āļāļēāļĢāļ™āļģāđ„āļ›āļ›āļāļīāļšāļąāļ•āļī

āļ—āļģāđ„āļĄāļĄāļąāļ™āļ–āļķāļ‡āļŠāļģāļ„āļąāļ

  • āļšāļĢāļīāļšāļ—āđāļĨāļ°āļāļŽ. āļšāļĢāļīāļšāļ—āļ—āļēāļ‡āļ­āļļāļ•āļŠāļēāļŦāļāļĢāļĢāļĄāđ€āļ›āđ‡āļ™āļ•āļąāļ§āļāļģāļŦāļ™āļ”āļ§āđˆāļēāđāļ™āļ§āļ„āļīāļ” AI āļˆāļ°āļĢāļ­āļ”āļˆāļēāļāļāļēāļĢāļŠāļąāļĄāļœāļąāļŠāļāļąāļšāļ„āļ§āļēāļĄāđ€āļ›āđ‡āļ™āļˆāļĢāļīāļ‡āļŦāļĢāļ·āļ­āđ„āļĄāđˆ
  • āļāļēāļĢāļ„āļ§āļšāļ„āļļāļĄāļ„āļļāļ“āļ āļēāļž. āļ‚āđ‰āļ­āļˆāļģāļāļąāļ”āļ‚āļ­āļ‡āđ‚āļ”āđ€āļĄāļ™āļĄāļĩāļ­āļīāļ—āļ˜āļīāļžāļĨāļ•āđˆāļ­āļ­āļąāļ•āļĢāļēāļ‚āđ‰āļ­āļœāļīāļ”āļžāļĨāļēāļ”āļ—āļĩāđˆāļĒāļ­āļĄāļĢāļąāļšāđ„āļ”āđ‰āđāļĨāļ°āđāļšāļšāļˆāļģāļĨāļ­āļ‡āļāļēāļĢāļ„āļ§āļšāļ„āļļāļĄāļ”āļđāđāļĨ
  • āļŠāļĢāđ‰āļēāļ‡āļ—āļēāļ‡āđ€āļĨāļ·āļ­āļ. āļāļēāļĢāļ›āļĢāļąāļšāđƒāļŠāđ‰āļ—āļĩāđˆāļ›āļĢāļ°āļŠāļšāļ„āļ§āļēāļĄāļŠāļģāđ€āļĢāđ‡āļˆāļˆāļ°āļ›āļĢāļąāļšāļ„āļ§āļēāļĄāļŠāļēāļĄāļēāļĢāļ–āļ—āļēāļ‡āđ€āļ—āļ„āļ™āļīāļ„āđƒāļŦāđ‰āļŠāļ­āļ”āļ„āļĨāđ‰āļ­āļ‡āļāļąāļšāđ€āļ§āļīāļĢāđŒāļāđ‚āļŸāļĨāļ§āđŒāđāļ™āļ§āļŦāļ™āđ‰āļē

āļĢāļ°āļ§āļąāļ‡

  • āļ‚āđ‰āļ­āļāļģāļŦāļ™āļ”āļ”āđ‰āļēāļ™āļāļŽāļĢāļ°āđ€āļšāļĩāļĒāļšāļ­āļēāļˆāļ—āļģāđƒāļŦāđ‰āļ•āđ‰āļ™āđāļšāļšāļ—āļĩāđˆāđāļ‚āđ‡āļ‡āđāļāļĢāđˆāļ‡āđ€āļ›āđ‡āļ™āđ‚āļĄāļ†āļ°āđ„āļ”āđ‰
  • āļ‚āđ‰āļ­āļĄāļđāļĨāđƒāļ™āļ­āļ”āļĩāļ•āļ­āļēāļˆāđ€āļ‚āđ‰āļēāļĢāļŦāļąāļŠāļ­āļ„āļ•āļīāļ—āļĩāđˆāđ€āļ›āđ‡āļ™āļ­āļąāļ™āļ•āļĢāļēāļĒāļ•āđˆāļ­āļŠāļļāļĄāļŠāļ™āļšāļēāļ‡āđāļŦāđˆāļ‡
  • āļĢāļ°āļšāļšāđ€āļ”āļīāļĄāļŠāļēāļĄāļēāļĢāļ–āļŠāļĢāđ‰āļēāļ‡āļ›āļąāļāļŦāļēāļ„āļ­āļ‚āļ§āļ”āđƒāļ™āļāļēāļĢāļšāļđāļĢāļ“āļēāļāļēāļĢāđāļĨāļ°āļ•āđ‰āļ™āļ—āļļāļ™āđāļ­āļšāđāļāļ‡āđ„āļ”āđ‰

āļ‚āļąāđ‰āļ™āļ•āļ­āļ™āļ•āđˆāļ­āđ„āļ›

  1. āđƒāļŦāđ‰āļœāļđāđ‰āđ€āļŠāļĩāđˆāļĒāļ§āļŠāļēāļāđ‚āļ”āđ€āļĄāļ™āļĄāļĩāļŠāđˆāļ§āļ™āļĢāđˆāļ§āļĄāļ•āļąāđ‰āļ‡āđāļ•āđˆāļāļēāļĢāļāļģāļŦāļ™āļ”āļāļĢāļ­āļšāļ›āļąāļāļŦāļēāđ„āļ›āļˆāļ™āļ–āļķāļ‡āļāļēāļĢāļ›āļĢāļ°āđ€āļĄāļīāļ™
  2. āļ­āļ­āļāđāļšāļšāđ€āļŠāđ‰āļ™āļ—āļēāļ‡āļāļēāļĢāļ•āļĢāļ§āļˆāļŠāļ­āļšāđāļĨāļ°āđ€āļ­āļāļŠāļēāļĢāļ›āļĢāļ°āļāļ­āļšāļāđˆāļ­āļ™āļāļēāļĢāđ€āļ›āļīāļ”āļ•āļąāļ§
  3. āļ•āļĢāļ§āļˆāļŠāļ­āļšāļāļēāļĢāļ›āļāļīāļšāļąāļ•āļīāļ•āļēāļĄāļ‚āđ‰āļ­āļāļģāļŦāļ™āļ”āđāļĨāļ°āļ āļēāļĢāļ°āļœāļđāļāļžāļąāļ™āļ”āđ‰āļēāļ™āļ„āļ§āļēāļĄāļ›āļĨāļ­āļ”āļ āļąāļĒāļ•āļąāđ‰āļ‡āđāļ•āđˆāđ€āļ™āļīāđˆāļ™āđ†
  4. āđ€āļ›āļīāļ”āļ•āļąāļ§āđ€āļ›āđ‡āļ™āļĢāļ°āļĒāļ°āđ‚āļ”āļĒāļĄāļĩāđ€āļāļ“āļ‘āđŒāļāļēāļĢāļŦāļĒāļļāļ”āđāļĨāļ°āļĒāđ‰āļ­āļ™āļāļĨāļąāļšāļ—āļĩāđˆāļŠāļąāļ”āđ€āļˆāļ™

āļŠāļģāļĢāļ§āļˆāļ•āđˆāļ­āđ„āļ›

āļˆāļ”āļŦāļĄāļēāļĒāļ‚āđˆāļēāļ§āļŸāļĢāļĩ

āļĢāļąāļšāļŠāļĢāļļāļ› AI āļĢāļēāļĒāļ§āļąāļ™

āđ€āļĢāļ·āđˆāļ­āļ‡āļĢāļēāļ§ AI āļ—āļĩāđˆāļ•āļĢāļ§āļˆāļŠāļ­āļšāđāļĨāđ‰āļ§ 3 āđ€āļĢāļ·āđˆāļ­āļ‡āļ—āļļāļāļ§āļąāļ™āļ—āļģāļ‡āļēāļ™ āđ€āļŠāđ‰āļē, āđ€āļ‚āļĩāļĒāļ™āđ€āļ›āđ‡āļ™āļ āļēāļĐāļēāļ­āļąāļ‡āļāļĪāļĐāļ˜āļĢāļĢāļĄāļ”āļē āļŸāļĢāļĩāļ•āļĨāļ­āļ”āđ„āļ› āđ„āļĄāđˆāļĄāļĩāđ‚āļ†āļĐāļ“āļē

āļ­āļĩāđ€āļĄāļĨāļŦāļ™āļķāđˆāļ‡āļ‰āļšāļąāļšāļ—āļļāļāļ§āļąāļ™āļ—āļģāļ‡āļēāļ™ āļĒāļāđ€āļĨāļīāļāļāļēāļĢāļŠāļĄāļąāļ„āļĢāđƒāļ™āļ„āļĨāļīāļāđ€āļ”āļĩāļĒāļ§ āđ€āļĢāļēāđ„āļĄāđˆāđ€āļ„āļĒāļ‚āļēāļĒāļŦāļĢāļ·āļ­āđāļŠāļĢāđŒāļ—āļĩāđˆāļ­āļĒāļđāđˆāļ­āļĩāđ€āļĄāļĨāļ‚āļ­āļ‡āļ„āļļāļ“

āļ—āļ”āļŠāļ­āļšāļ•āļąāļ§āđ€āļ­āļ‡

Take the AI in Kidney Disease and Nephrology quiz

āļ‚āđ‰āļ­āđ€āļŠāļ™āļ­āđāļ™āļ°āļ—āļąāļ™āļ—āļĩāļŠāļģāļŦāļĢāļąāļšāļ—āļļāļāļ„āļģāļ•āļ­āļš āđāļĨāļ°āđƒāļšāļĢāļąāļšāļĢāļ­āļ‡āļ—āļĩāđˆāļŠāļēāļĄāļēāļĢāļ–āđāļŠāļĢāđŒāđ„āļ”āđ‰āļžāļĢāđ‰āļ­āļĄ ID āļ—āļĩāđˆāļ•āļĢāļ§āļˆāļŠāļ­āļšāđ„āļ”āđ‰āđ€āļĄāļ·āđˆāļ­āļ„āļļāļ“āļœāđˆāļēāļ™āļŦāļĨāļąāļāļŠāļđāļ•āļĢ

āđ€āļĢāļīāđˆāļĄāđāļšāļšāļ—āļ”āļŠāļ­āļš

āļŠāļ™āļąāļšāļŠāļ™āļļāļ™āļāļēāļĢāļĻāļķāļāļĐāļē AI āļŸāļĢāļĩ AI Understanding āđ€āļ›āđ‡āļ™āļ­āļ‡āļ„āđŒāļāļĢāđ„āļĄāđˆāđāļŠāļ§āļ‡āļŦāļēāļœāļĨāļāļģāđ„āļĢ 501(c)(3) — āđ„āļĄāđˆāļĄāļĩāđ‚āļ†āļĐāļ“āļē āđ„āļĄāđˆāļĄāļĩāļāļģāđāļžāļ‡āđ€āļ‡āļīāļ™, āļ•āļĨāļ­āļ”āđ„āļ› āļšāļĢāļīāļˆāļēāļ„

āļ„āļģāļ–āļēāļĄāļ—āļĩāđˆāļžāļšāļšāđˆāļ­āļĒ

What is AI in Kidney Disease and Nephrology?

AI kidney models use electronic records and laboratory trends to estimate risk of acute kidney injury or chronic kidney disease progression. They matter because earlier risk signals may help a care team focus review, but a prediction is not a diagnosis and does not replace clinician judgment or guideline-based monitoring.

KDIGO āđ€āļ™āđ‰āļ™āļāļēāļĢāļ§āļąāļ”āđāļšāļšāđƒāļ”āđƒāļ™āļāļēāļĢāļ•āļīāļ”āļ•āļēāļĄāļ„āļ§āļēāļĄāļāđ‰āļēāļ§āļŦāļ™āđ‰āļēāļ‚āļ­āļ‡ CKD

āļšāļąāļ™āļ—āļķāļāļ„āļđāđˆāļĄāļ·āļ­ KDIGO āđāļ™āļ°āļ™āļģāđƒāļŦāđ‰āļ›āļĢāļ°āđ€āļĄāļīāļ™ GFR āđāļĨāļ° albuminuria āđƒāļ™āļāļēāļĢāļ•āļīāļ”āļ•āļēāļĄ CKD

āđ‚āļĄāđ€āļ”āļĨ AKI āļŠāļēāļĄāļēāļĢāļ–āļ§āļīāđ€āļ„āļĢāļēāļ°āļŦāđŒāļ‚āđ‰āļ­āļĄāļđāļĨāļ›āļĢāļ°āđ€āļ āļ—āđƒāļ”āđ„āļ”āđ‰āļšāđ‰āļēāļ‡

āļ„āļđāđˆāļĄāļ·āļ­āļ™āļĩāđ‰āļˆāļ°āļ­āļ˜āļīāļšāļēāļĒāđāļšāļšāļˆāļģāļĨāļ­āļ‡āđ‚āļ”āļĒāđƒāļŠāđ‰āļŦāđ‰āļ­āļ‡āļ›āļāļīāļšāļąāļ•āļīāļāļēāļĢāļ•āļēāļĄāļĒāļēāļ§āđāļĨāļ°āļ‚āđ‰āļ­āļĄāļđāļĨāļšāļąāļ™āļ—āļķāļāļŠāļļāļ‚āļ āļēāļžāđāļšāļšāļ­āļīāđ€āļĨāđ‡āļāļ—āļĢāļ­āļ™āļīāļāļŠāđŒ

āđ€āļŦāļ•āļļāđƒāļ”āļāļēāļĢāļĻāļķāļāļĐāļēāļāļēāļĢāļĢāļąāļšāđ€āļ‚āđ‰āļē 495,971 āļ„āļ™āļˆāļķāļ‡āđ„āļĄāđˆāļĢāļ°āļšāļļāļ§āđˆāļēāļāļēāļĢāđāļˆāđ‰āļ‡āđ€āļ•āļ·āļ­āļ™ AI āļŠāđˆāļ§āļĒāļ›āļĢāļąāļšāļ›āļĢāļļāļ‡āļœāļĨāļĨāļąāļžāļ˜āđŒāļ‚āļ­āļ‡āļœāļđāđ‰āļ›āđˆāļ§āļĒ

āļāļēāļĢāļĻāļķāļāļĐāļēāđāļšāļšāļŦāļĨāļēāļĒāļĻāļđāļ™āļĒāđŒāļ›āļĢāļ°āđ€āļĄāļīāļ™āļ›āļĢāļ°āļŠāļīāļ—āļ˜āļīāļ āļēāļžāļāļēāļĢāļ—āļģāļ™āļēāļĒāļĒāđ‰āļ­āļ™āļŦāļĨāļąāļ‡ āđ„āļĄāđˆāđ„āļ”āđ‰āļ—āļ”āļŠāļ­āļšāļāļēāļĢāđāļ—āļĢāļāđāļ‹āļ‡āļāļēāļĢāđāļˆāđ‰āļ‡āđ€āļ•āļ·āļ­āļ™āđƒāļ™āļ­āļ™āļēāļ„āļ•āļŦāļĢāļ·āļ­āļœāļĨāļ›āļĢāļ°āđ‚āļĒāļŠāļ™āđŒāļ•āđˆāļ­āļœāļĨāļĨāļąāļžāļ˜āđŒāļ‚āļ­āļ‡āļœāļđāđ‰āļ›āđˆāļ§āļĒ

āđ€āļŦāļ•āļļāđƒāļ”āļˆāļķāļ‡āļ—āļ”āļŠāļ­āļšāđāļšāļšāļˆāļģāļĨāļ­āļ‡āđƒāļ™āđ‚āļĢāļ‡āļžāļĒāļēāļšāļēāļĨāļ—āļĩāđˆāđāļ•āļāļ•āđˆāļēāļ‡āļˆāļēāļāļŠāļ–āļēāļ™āļ—āļĩāđˆāļāļķāļāļ­āļšāļĢāļĄ

āļāļēāļĢāļ•āļĢāļ§āļˆāļŠāļ­āļšāļ āļēāļĒāļ™āļ­āļāļŠāđˆāļ§āļĒāļ›āļĢāļ°āđ€āļĄāļīāļ™āļ›āļĢāļ°āļŠāļīāļ—āļ˜āļīāļ āļēāļžāđƒāļ™āļŠāļ āļēāļžāđāļ§āļ”āļĨāđ‰āļ­āļĄāļ—āļĩāđˆāđāļ•āļāļ•āđˆāļēāļ‡āļāļąāļ™

āļ‚āđ‰āļ­āļĄāļđāļĨāļŦāđ‰āļ­āļ‡āļ›āļāļīāļšāļąāļ•āļīāļāļēāļĢāļžāļ·āđ‰āļ™āļāļēāļ™āļ—āļĩāđˆāļ‚āļēāļ”āļŦāļēāļĒāđ„āļ›āļĄāļĩāļ›āļĢāļ°āđ‚āļĒāļŠāļ™āđŒāļ­āļ°āđ„āļĢāļ•āđˆāļ­āļāļēāļĢāļ—āļģāļ™āļēāļĒ

āļāļēāļĢāļ§āļąāļ”āļ—āļĩāđˆāļ‚āļēāļ”āļŦāļēāļĒāđ„āļ›āļŦāļĢāļ·āļ­āļāļĢāļ°āļˆāļąāļ”āļāļĢāļ°āļˆāļēāļĒāļ­āļēāļˆāļŠāđˆāļ‡āļœāļĨāļ•āđˆāļ­āļ­āļīāļ™āļžāļļāļ•āđāļĨāļ°āļāļēāļĢāļ•āļĩāļ„āļ§āļēāļĄāđ‚āļĄāđ€āļ”āļĨ

āđ€āļĢāļĩāļĒāļ™āļĢāļđāđ‰āļ•āđˆāļ­āđ„āļ›

āļ„āļģāđāļ™āļ°āļ™āļģāļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡

āļ„āļģāđāļ™āļ°āļ™āļģāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄāļ—āļĩāđˆāđ€āļĨāļ·āļ­āļāļŠāļģāļŦāļĢāļąāļšāļŦāļąāļ§āļ‚āđ‰āļ­āļ™āļĩāđ‰

āļ•āđˆāļ­āđ„āļ›āļ„āļģāđāļ™āļ°āļ™āļģāļ•āđˆāļ­āđ„āļ›

āļāļēāļĢāļ—āļģāļ™āļēāļĒāļāļēāļĢāļšāļēāļ”āđ€āļˆāđ‡āļšāļ—āļĩāđˆāđ„āļ•āđ€āļ‰āļĩāļĒāļšāļžāļĨāļąāļ™āđ‚āļ”āļĒ AI

āļ­āļļāļ•āļŠāļēāļŦāļāļĢāļĢāļĄ

āļĢāļąāļšāđƒāļšāļĢāļąāļšāļĢāļ­āļ‡ AI āļŸāļĢāļĩāļŦāļĨāļąāļāļŠāļđāļ•āļĢāđāļĨāļ°āļāļēāļĢāļŠāļ­āļšāļŠāļąāđ‰āļ™ āđ† āļŸāļĢāļĩ āđ„āļĄāđˆāļĄāļĩāļ„āđˆāļēāđƒāļŠāđ‰āļˆāđˆāļēāļĒ āđ„āļĄāđˆāļĄāļĩāļšāļąāļ•āļĢāđ€āļ„āļĢāļ”āļīāļ• āļ›āļĢāļ°āļĄāļēāļ“ 2.5 āļŠāļąāđˆāļ§āđ‚āļĄāļ‡āđ€āļĢāļīāđˆāļĄāļ•āđ‰āļ™āļŸāļĢāļĩ →